Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy

• Status: Completed
• Trial end date: 2017-09-05
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients. The primary outcome variable will be reduction of shoulder pain.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Any type of open thoracotomy or video-assisted thoracoscopic surgery (VATS)

• Presence of post-operative ISP, VAS>5/10

• American Society of Anesthesiologists Class 1 - 4

• No allergy to lidocaine

Exclusion Criteria:

• American Society of Anesthesiologists Class 5

• Allergy to lidocaine

• Nasal pathology (e.g., deviated septum)

• Bleeding diathesis

• Any patient who the PI feels will be unable to comply with all protocol related procedures

• Shoulder pain prior to thoracotomy